OpenAI Chatgpt CEO Invests $180 Million in Biotech Startup’s Research to Prolong Human Life

Published on May 12, 2023

Sam Altman, the CEO of OpenAI, has invested $180 million in Retro Biosciences, a biotech startup that aims to extend the human lifespan by 10 years through innovative therapies that counteract age-related ailments. Altman’s investment will help Retro Biosciences achieve its preliminary proofs of concept and maintain its operations over the next decade. Altman’s interest […]

The post OpenAI Chatgpt CEO Invests $180 Million in Biotech Startup’s Research to Prolong Human Life appeared first on BioTecNika.

Continue reading on website
Other news

5 cell therapy companies you should know about

May 12, 2023
Cell therapy has come a long way in recent years, with many biotech companies now specializing in the development of cell therapies to treat various diseases. In this article we take a look at five of those companies. Cell therapy refers to the transplantation of human cells in order to replace or repair damaged ones […]The post 5 cell therapy companies you should know about appeared first on Labi

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia

May 12, 2023
Riga, Latvia, 8 May 2023 – LATVIA MGI TECH, SIA, ("MGI Latvia") a subsidiary of MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today announced the official opening of its large-scale production line in Latvia. As MGI's largest regional hub for the European market, the facility based in Riga will see assembly and production of DNBSEQ-G400